(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine

C15H15N5O2 — CID 98575907

IUPAC(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine
SMILESCc1noc([C@H]2COCCN2c2cnc3ccccc3n2)n1
InChIInChI=1S/C15H15N5O2/c1-10-17-15(22-19-10)13-9-21-7-6-20(13)14-8-16-11-4-2-3-5-12(11)18-14/h2-5,8,13H,6-7,9H2,1H3/t13-/m1/s1
InChIKeyBPHKOXPLYZKTMQ-CYBMUJFWSA-N
MW297.32 g/mol
LogP1.90
Rot. Bonds2

About (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine

(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine (PubChem CID 98575907) has the molecular formula C15H15N5O2 and a molecular weight of 297.32 g/mol. Its IUPAC name is (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine.

Molecular Properties

Compound Name(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine
PubChem CID98575907
Molecular FormulaC15H15N5O2
Molecular Weight297.32 g/mol
Exact Mass297.12
IUPAC Name(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine
SMILESCc1noc([C@H]2COCCN2c2cnc3ccccc3n2)n1
InChIInChI=1S/C15H15N5O2/c1-10-17-15(22-19-10)13-9-21-7-6-20(13)14-8-16-11-4-2-3-5-12(11)18-14/h2-5,8,13H,6-7,9H2,1H3/t13-/m1/s1
InChIKeyBPHKOXPLYZKTMQ-CYBMUJFWSA-N
XLogP1.90
TPSA77.17 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds2
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500297.32
LogP ≤ 51.90
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(3R)-3-(3,5-dimethyl-1H-pyrazol-4-yl)-4-quinoxalin-2-ylmorpholine
CID 97330544
3-methyl-5-[(3R)-1-quinoxalin-2-ylpiperidin-3-yl]-1,2,4-oxadiazole
CID 94496992
(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-[(2-phenyl-1H-imidazol-5-yl)methyl]morpholine
CID 99825862
(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-[(1-methylpyrrol-2-yl)methyl]morpholine
CID 99825829
(3S)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(2-phenylpyrimidin-4-yl)morpholine
CID 97344130
4-quinoxalin-2-yl-1,4-oxazepane
CID 134160732
4-[(2-ethylpyrazol-3-yl)methyl]-3-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine
CID 91650718
[(1S,2S,4S)-2-bicyclo[2.2.1]heptanyl]-[(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)morpholin-4-yl]methanone
CID 129429155
2-[(2R)-2-(1-methylpyrazol-4-yl)pyrrolidin-1-yl]quinoxaline
CID 95342310
N-(3,5-dimethylphenyl)-2-[(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)morpholin-4-yl]acetamide
CID 99777442
(3R)-4-(1,4-dioxaspiro[4.5]decan-8-ylmethyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine
CID 124622170
4-[6-methyl-2-(4-quinoxalin-2-ylpiperazin-1-yl)pyrimidin-4-yl]morpholine
CID 154883227

Frequently Asked Questions

What is the IUPAC name of (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine?
The IUPAC name of (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine (CID 98575907) is (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine.
What is the SMILES notation for (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine?
The canonical SMILES for (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine is Cc1noc([C@H]2COCCN2c2cnc3ccccc3n2)n1.
What is the InChIKey of (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine?
The InChIKey is BPHKOXPLYZKTMQ-CYBMUJFWSA-N. The full InChI is InChI=1S/C15H15N5O2/c1-10-17-15(22-19-10)13-9-21-7-6-20(13)14-8-16-11-4-2-3-5-12(11)18-14/h2-5,8,13H,6-7,9H2,1H3/t13-/m1/s1.
What are the key properties of (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine?
(3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine has a molecular weight of 297.32 g/mol, XLogP of 1.90, 2 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4-quinoxalin-2-ylmorpholine is sourced from PubChem (CID 98575907), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).